{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:04:31Z","timestamp":1789103071748,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.022","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T13:55:49Z","timestamp":1579874149000},"page":"1933-1942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-2031","authenticated-orcid":false,"given":"Anna","family":"Kazakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thedi","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"P\u00e4kkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Waris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Soukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Julkunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.022_b0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra1208802","article-title":"Pandemic preparedness and response \u2014 lessons from the H1N1 Influenza of 2009","volume":"370","author":"Fineberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.01.022_b0010","doi-asserted-by":"crossref","unstructured":"Simona Puzelli, Livia Di Trani, Concetta Fabiani LC, Maria Alessandra De Marco, Ilaria Capua JFA, Maria Zambon and ID. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J Infect Dis; 2005. doi:192:1318\u201322.","DOI":"10.1086\/444390"},{"key":"10.1016\/j.vaccine.2020.01.022_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0950268800001291","article-title":"An epidemiological study of influenza viruses among Chinese farm families with household ducks and pigs","volume":"117","author":"Shu","year":"1996","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.01.022_b0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00705-009-0319-7","article-title":"Serological survey of avian H5N2-subtype influenza virus infections in human populations","volume":"154","author":"Yamazaki","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0025","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.44.30388","article-title":"Weighing serological evidence of human exposure to animal influenza viruses - a literature review","volume":"21","author":"Sikkema","year":"2016","journal-title":"Euro Surveill"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.01.022_b0030","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0264-410X(02)00123-8","article-title":"The importance of animal influenza for human disease","volume":"20","author":"Webster","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.022_b0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/vaccines2040707","article-title":"Overview of serological techniques for influenza vaccine evaluation: past, present and future","volume":"2","author":"Trombetta","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2020.01.022_b0040","unstructured":"Plotkin SA, Orenstein WA, Offit PA. Vaccines. n.d."},{"key":"10.1016\/j.vaccine.2020.01.022_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-0758-8_2","article-title":"Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus","volume":"1161","author":"Pedersen","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0050","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.vaccine.2019.03.078","article-title":"Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses","volume":"37","author":"Haveri","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.022_b0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10654-006-9071-4","article-title":"Response to influenza vaccine in people with non-protective HI antibody titers","volume":"21","author":"Baldo","year":"2006","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0060","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2020.01.022_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.vaccine.2020.01.022_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4939-7828-1_17","article-title":"Measuring vaccine responses in the multiplex era","volume":"1781","author":"Ayling","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0080","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/s41598-019-39276-1","article-title":"Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011\u20132018","volume":"9","author":"Jorquera","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.01.022_b0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.270.5235.467","article-title":"Quantitative monitoring of gene expression patterns with a complementary DNA Microarray","volume":"270","author":"Schena","year":"1995","journal-title":"Science (80-)"},{"key":"10.1016\/j.vaccine.2020.01.022_b0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/bib\/bbv092","article-title":"Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients","volume":"17","author":"Yasrebi","year":"2016","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.vaccine.2020.01.022_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/820304","article-title":"Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera","volume":"2014","author":"Selvarajah","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.vaccine.2020.01.022_b0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1128\/CVI.00190-15","article-title":"Profiling humoral immune responses to clostridium difficile-specific antigens by protein microarray analysis","volume":"22","author":"Negm","year":"2015","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0105","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1023\/B:BILE.0000045653.92719.a4","article-title":"Development and evaluation of a protein microarray chip for diagnosis of hepatitis C virus","volume":"26","author":"Yuk","year":"2004","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2020.01.022_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00236-19","article-title":"Development and standardization of a high-throughput multiplex immunoassay for the simultaneous quantification of specific antibodies to five respiratory syncytial virus proteins","volume":"4","author":"Schepp","year":"2019","journal-title":"MSphere"},{"key":"10.1016\/j.vaccine.2020.01.022_b0115","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2018.07.048","article-title":"Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines","volume":"36","author":"Itell","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.022_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15321819.2018.1563551","article-title":"The use of multiplexing technology in the immunodiagnosis of infectious agents","volume":"40","author":"Engin","year":"2019","journal-title":"J Immunoass Immunochem"},{"key":"10.1016\/j.vaccine.2020.01.022_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064555","article-title":"Characterization of influenza vaccine immunogenicity using influenza antigen microarrays","volume":"8","author":"Price","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.022_b0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/JCM.01330-08","article-title":"Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses","volume":"47","author":"Gall","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0135","doi-asserted-by":"crossref","first-page":"e0134484","DOI":"10.1371\/journal.pone.0134484","article-title":"A multiplex label-free approach to avian influenza surveillance and serology","volume":"10","author":"Bucukovski","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.022_b0140","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00592-18","article-title":"Protein microarray analysis of the specificity and cross-reactivity of influenza virus hemagglutinin-specific antibodies","volume":"3","author":"Nakajima","year":"2018","journal-title":"MSphere"},{"key":"10.1016\/j.vaccine.2020.01.022_b0145","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1038\/emi.2017.98","article-title":"Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards","volume":"6","author":"Meade","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.01.022_b0150","doi-asserted-by":"crossref","first-page":"e108043","DOI":"10.1371\/journal.pone.0108043","article-title":"Getting more out of less \u2013 a quantitative serological screening tool for simultaneous detection of multiple influenza A hemagglutinin-types in chickens","volume":"9","author":"Freidl","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.022_b0155","doi-asserted-by":"crossref","DOI":"10.2144\/000114041","article-title":"Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses","volume":"54","author":"Desbien","year":"2013","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2020.01.022_b0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrmicro1530","article-title":"Glycan microarray technologies: tools to survey host specificity of influenza viruses","volume":"4","author":"Stevens","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0165","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1586\/erv.10.141","article-title":"Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine","volume":"9","author":"Walker","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.01.022_b0170","doi-asserted-by":"crossref","first-page":"e108538","DOI":"10.1371\/journal.pone.0108538","article-title":"Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009\u20132010 and 2010\u20132011 in Finland","volume":"9","author":"Syrj\u00e4nen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.01.022_b0175","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/acs.analchem.6b00337","article-title":"Spectrally and spatially multiplexed serological array-in-well assay utilizing two-color upconversion luminescence imaging","volume":"88","author":"Kale","year":"2016","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2020.01.022_b0180","article-title":"Serological array-in-well multiplex assay reveals a high rate of respiratory virus infections and reinfections in young children","author":"Anna","year":"2019","journal-title":"MSphere"},{"key":"10.1016\/j.vaccine.2020.01.022_b0185","series-title":"WHO Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2020.01.022_b0190","first-page":"1","article-title":"Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life","author":"Kutsaya","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.01.022_b0195","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2020.01.022_b0200","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/j.vaccine.2012.02.077","article-title":"Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines\u2014an effective EU regulatory approach","volume":"30","author":"Wagner","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.022_b0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.vaccine.2011.11.019","article-title":"Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard","volume":"30","author":"Wood","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.022_b0210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.05537-11","article-title":"Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus","volume":"19","author":"Smits","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.01.022_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2016.12.006","article-title":"A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus","volume":"241","author":"Schepp","year":"2017","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.01.022_b0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2020.01.022_b0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2020.01.022_b0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","article-title":"Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers","volume":"61B","author":"Khan","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.vaccine.2020.01.022_b0235","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J Gerontol Ser A Biol Sci Med Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:08Z","timestamp":1759401608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20300372"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}